Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms
Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms Further strengthens Centrient Pharmaceuticals' position as the global business-to-business industry leader in beta-lactam antibiotics Broadens Centrient Pharmaceuticals' product portfolio with sterile injectable Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms, able to further meet the needs of customers in these segments and become a preferred partner for customers Brings in-house manufacturing capabilities for high-qu...
Source: finanznachrichten.de